|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Acetazolamide#Contraindications]] |
| {{Acetazolamide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| | |
| [[Hypersensitivity]] to acetazolamide or any excipients in the formulation. Since acetazolamide is a sulfonamide derivative, cross sensitivity between acetazolamide, sulfonamides and other sulfonamide derivatives is possible. | |
| | |
| Acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. It is contraindicated in patients with cirrhosis because of the risk of development of hepatic [[encephalopathy]]. | |
| | |
| Long-term administration of DIAMOX is contraindicated in patients with chronic non-congestive angle-closure [[glaucoma]] since it may permit organic closure of the angle to occur while the worsening [[glaucoma]] is masked by lowered intraocular pressure.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e47451-2bc8-496e-88ad-c10002ee8e22 | publisher = | date = | accessdate = 25 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{Anticonvulsants}}
| |
| {{Antiglaucoma preparations and miotics}}
| |
| {{Diuretics}}
| |
| | |
| [[Category:Carbonic anhydrase inhibitors]]
| |
| [[Category:Mountaineering and health]]
| |
| [[Category:Anticonvulsants]]
| |
| [[Category:Sulfonamides]]
| |
| [[Category:World Health Organization essential medicines]]
| |
| [[Category:Thiadiazoles]]
| |
| [[Category:Amides]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |